Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash provided by (used for) operating activities
Cash provided by (used for) operating activities	$ (77)	$ 350
Investing activities:
Purchases of property, plant and equipment	(100)	(63)
Proceeds from sale of property, plant and equipment	3	2
Payments for acquisitions of businesses, net of cash acquired	0	(321)
Payments for (Proceeds from) Other Investing Activities	23	0
Payments for investments and acquisitions of certain technologies	(2)	(28)
Cash provided by (used for) investing activities	(76)	(410)
Financing activities:
Payment of contingent consideration and royalty rights previously established in purchase accounting	(76)	(7)
Payments on short-term borrowings	(300)	(1,000)
Proceeds from short-term borrowings, net of debt issuance costs	1,000	0
Net increase (decrease) in commercial paper	(714)	370
Payments on borrowings from credit facilities	(479)	0
Proceeds from borrowings on credit facilities	1,839	0
Payments on long-term borrowings and debt extinguishment costs	(1,000)	(1,472)
Proceeds from long-term borrowings, net of debt issuance costs	0	4,243
Cash used to net share settle employee equity awards	(57)	(60)
Proceeds from issuances of shares of common stock	42	53
Cash provided by (used for) financing activities	256	2,127
Effect of foreign exchange rates on cash	(9)	0
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents	93	2,067
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period	607	829
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	700	2,896
Supplemental Information
Stock-based compensation expense	42	36
Fair value of contingent consideration recorded in purchase accounting	0	$ 87
Non-cash impact of transferred royalty rights	$ (23)